Agios Pharmaceuticals | AGIO - Market Capitalization


Agios Pharmaceuticals reported $1.81B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Astellas Pharma JPY 4.78T 582.95B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Daiichi Sankyo JPY 5.22T 356.74B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Exelixis USD 19.82B 5.34B Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
Merck USD 375.59B 17.09B Nov/2026
Moderna USD 99.14B 22.26B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Novartis USD 328.21B 54.92B Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026